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We have read the paper by Wang and Zhang1. We are pleased to see that other authors 
further illustrate and also find nice properties for an evaluation tool that we first used more than ten 
years ago2, presented at PAGE in 20003 and published extensively first in 20064. However we disagree 
with some of the conclusions made by the authors, and we feel that an important reference should 
have been included in their manuscript. 
As Wang and Zhang point out themselves, what they call SVPC is nothing other than the 
prediction discrepancies (pd) named that way, after being called pseudo-residuals by Mentré and 
Escolano in 20064. It is therefore misleading to present SVPC as something novel when in fact it goes 
back on something that our group has published and presented in conferences.  
Plots of SVPC versus time in the paper by Wang and Zhang1 are very similar to plots of pd 
versus time in Mentré and Escolano4, therefore we disagree with the statement on page 2 that  
"Neither pd nor npde was intended/recommended for evaluation of model predictions over a time 
course”. pd and npde were developed for their improved statistical properties over linearisation-
based residuals but are used as visual diagnostic tools in a similar way. 
Also the paper is not complete when it comes to the current state of literature. Wang and 
Zang1 missed one important reference, in which we have compared pd, npde, VPC, as well as tests 
based on prediction intervals with or without decorrelation5. We have also proposed tests for 
covariate models illustrating how npde can be used to evaluate covariate models. Their paper is 
rather inaccurate when comparing the properties of the pd to those of the npde. The idea behind the 
npde, as recalled in the paper, is to decorrelate observations within individuals. In Mentré and 
Escolano4, it had been shown that the type I error of the test based on pd was inflated when subjects 
contribute several observations, because of the within-subject correlation between observations, and 
it was anticipated that the decorrelation would improve this feature. Indeed, in Brendel et al.5  we 
have shown that the type I error of the npde is close to the expected 5% while the type I error for the 
pd or the test based on prediction intervals of the VPC was larger. In that paper, we performed a full 
simulation study, i.e. with several replications of the simulated data set, while in the manuscript of 
Wang and Zhang only one simulated dataset is given, from which it is very hard to draw meaningful 
conclusions. It is quite possible that for one simulated dataset the pd detects something that the 
npde does not, indeed, our simulations have shown that on a large number of simulated datasets, the 
tests with npde maintain type I error while the tests with pd have an increased type I error and hence 
a higher power. A discussion of the power to detect model misspecification should therefore take into 
account the increase in type I error under the null hypothesis. Also in their table V, there was a 
significant departure from 0 of the mean npde for the wrong model (p=0.03 with a Wilcoxon test). 
We would also like to take this opportunity to mention that more informative VPC graphs 
have been proposed by Wilkins6 et al in 2006, which use prediction intervals around the simulated 
percentiles, and that we have adapted these graphs to pd and npde7. In that paper, we made a case 
of using pd instead of npde to plot diagnostic graphs because the decorrelation tends to blur the 
relationship with time when used for visual diagnostics. 
Finally, we join Wang and Zhang to stress the nice properties of simulation-based model 
evaluation tools such as pd (SVPC) over VPC and to encourage readers to use them. 
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